Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vivus Inc (VVUS)

Vivus Inc (VVUS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,335
  • Shares Outstanding, K 17,867
  • Annual Sales, $ 69,760 K
  • Annual Income, $ -31,500 K
  • 60-Month Beta -0.84
  • Price/Sales 0.13
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade VVUS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.70
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.60
  • Number of Estimates 1
  • High Estimate -0.60
  • Low Estimate -0.60
  • Prior Year -0.56
  • Growth Rate Est. (year over year) -7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4369 +6.78%
on 07/13/20
1.1841 -60.60%
on 06/18/20
-0.6835 (-59.43%)
since 06/16/20
3-Month
0.4369 +6.78%
on 07/13/20
1.4700 -68.27%
on 06/08/20
-0.9135 (-66.20%)
since 04/16/20
52-Week
0.4369 +6.78%
on 07/13/20
4.7500 -90.18%
on 08/26/19
-2.9235 (-86.24%)
since 07/16/19

Most Recent Stories

More News
VIVUS Receives Court Approval of Joint Chapter 11 Plan of Reorganization

VIVUS, Inc. (the "Company"), a biopharmaceutical company, today announced that it has received approval from the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court") on...

VVUS : 0.4665 (-10.29%)
VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date

On November 10, 2020, VIVUS, Inc. (the "Company"), a biopharmaceutical company, filed the Second Amended Joint Prepackaged Chapter 11 Plan of Reorganization of VIVUS, Inc. and Its Affiliated Debtors [Docket...

VVUS : 0.4665 (-10.29%)
Delisting of Securities of KemPharm, Inc.; Endologix, Inc.; VIVUS, Inc.; SAExploration Holdings, Inc.; Ascena Retail Group, Inc.; and Global Eagle Entertainment Inc. from The Nasdaq Stock Market

The Nasdaq Stock Market announced today that it will delist the common stock of KemPharm, Inc. KemPharm, Inc.'s common stock was suspended on May 21, 2020 and has not traded on Nasdaq since that time....

ASNA : 0.6063 (-15.67%)
ELGX : 0.2200 (-23.88%)
KMPH : 6.02 (-0.33%)
NDAQ : 140.42 (-0.69%)
SAEX : 0.3000 (-51.61%)
VVUS : 0.4665 (-10.29%)
VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.

VIVUS, Inc. (Nasdaq: VVUS; the "Company"), a biopharmaceutical company, today announced that it has updated its agreement regarding its corporate debt with Icahn Enterprises Holdings L.P. (dba IEH Biopharma...

VVUS : 0.4665 (-10.29%)
Vivus: 1Q Earnings Snapshot

CAMPBELL, Calif. (AP) _ Vivus Inc. (VVUS) on Wednesday reported a loss of $5.2 million in its first quarter.

VVUS : 0.4665 (-10.29%)
VIVUS Reports First Quarter 2020 Financial Results

Company to host conference call today at 4:30pm ET

VVUS : 0.4665 (-10.29%)
VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020

VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2020 after the market close on Wednesday, May 6, 2020. The Company...

VVUS : 0.4665 (-10.29%)
VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt

VIVUS, Inc. (Nasdaq: VVUS; the "Company"), a biopharmaceutical company, today announced an agreement regarding its corporate debt with IEH Biopharma LLC, which holds a principal amount of approximately...

VVUS : 0.4665 (-10.29%)
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

VIVUS, Inc. (Nasdaq: VVUS; the "Company"), a biopharmaceutical company, today announced the completion of its previously announced registered direct offering of 7,218,750 shares of the Company's common...

VVUS : 0.4665 (-10.29%)
VitalTech Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules

VitalTech, a rapidly growing market leader in Virtual Care, announced today its partnership with VIVUS, Inc, a publicly held biopharmaceutical company (Nasdaq: VVUS). Leveraging VitalTech's industry-leading...

VVUS : 0.4665 (-10.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead investigational product in clinical development, Qnexa(TM), is expected to complete Phase 3 clinical trials for the treatment of obesity...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.5155
1st Resistance Point 0.4910
Last Price 0.4665
1st Support Level 0.4510
2nd Support Level 0.4355
3rd Support Level N/A

See More

52-Week High 4.7500
Fibonacci 61.8% 3.1024
Fibonacci 50% 2.5935
Fibonacci 38.2% 2.0845
Last Price 0.4665
52-Week Low 0.4369

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar